Jason B. Pieper, DVM, MS, DACVD, talks about the multiple therapies available for cases of moderate and severe atopic ...

If someone has atopic dermatitis during childhood, it’s likely they’ll have recurrent flares and need recurrent treatment. However, parents can help minimize their child’s flares by ...

Nemluvio has received approval from the European Commission to treat moderate to severe atopic dermatitis and prurigo ...

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate ...

Zabalafin Hydrogel holds potential for first comprehensive AD treatment with safety and patient tolerability profile for long-term, worry-free, continuous use "This is an incredibly important ...

The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the ...

Many skin conditions appear differently in melanated skin, leading to misdiagnosis and poor treatment. Understanding these ...

Treating eczema starts with a solid skincare routine, but you may need more than just moisturizer to get you through a ...

Nemluvio is now the first approved monoclonal antibody that specifically targets interleukin-31 receptor alpha ...